Unique ID issued by UMIN | UMIN000035980 |
---|---|
Receipt number | R000040982 |
Scientific Title | The effects of combination of maslinic acid supplementation and physical exercise on body composition: a randomized, double-blind, placebo-controlled trial |
Date of disclosure of the study information | 2019/03/05 |
Last modified on | 2020/02/23 09:33:58 |
The effects of combination of maslinic acid supplementation and physical exercise on body composition: a randomized, double-blind, placebo-controlled trial
Maslinic acid and daily exercise trial
The effects of combination of maslinic acid supplementation and physical exercise on body composition: a randomized, double-blind, placebo-controlled trial
Maslinic acid and daily exercise trial
Japan |
nothing
Adult |
Others
NO
To examine the effects of combination of maslinic acid (olive fruit extract) intake and daily physical exercise on body composition
Efficacy
muscle mass (baseline, after 6 weeks, after 12 weeks)
body weight, body mass index, body composition, one leg standing time with open eyes, 10-meters walking speed, 10-meters walking speed with obstruction, handgrip strength, isometric knee extension strength, QOL(SF-8), JKOM scores
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
YES
3
Prevention
Food |
The participants consume capusules including 30 mg maslinic acid per day after breakfast for 12 weeks. In addition, they practice the programmed strength training during the trial everyday.
The participants consume capusules including 60 mg maslinic acid per day after breakfast for 12 weeks. In addition, they practice the programmed strength training during the trial everyday.
The participants consume placebo capusules per day after breakfast for 12 weeks. In addition, they practice the programmed strength training during the trial everyday.
40 | years-old | <= |
85 | years-old | >= |
Male and Female
(1) 40 years of age or older
(2) can practice daily exercise (resistance training and walking)
(3) can agree to participate by their own will and provide written informed consent before entry.
(1) having allergy against olive
(2) pregnancy, and engagement in breast-feeding
(3) undergoing rehabilitation by knee or waist pain
(4) have participated another clinical trial within 3 month befer agreement
(5) judged inadequate for participation by the investigator.
90
1st name | Tetsu |
Middle name | |
Last name | Kinoshita |
Institute of Community Life Sciences Co., Ltd.
Social Epidemiology Institute
791-0243
1383-2 Hiraimachi, Matsuyama-city, Ehime
089-904-7811
tetsu@shin-science.co.jp
1st name | Tetsu |
Middle name | |
Last name | Kinoshita |
Institute of Community Life Sciences Co., Ltd.
Institute of Social Epidemiology
791-0243
1383-2 Hiraimachi, Matsuyama-city, Ehime
089-904-7811
tetsu@shin-science.co.jp
Institute of Community Life Sciences Co., Ltd.
NIPPON FLOUR MILLS CO., LTD.
Profit organization
JAP
Institutional Review Borad, Sapporo Urinokai Hospital
11-186, Yurigahara, Kita-ku, Sapporo, Hokkaido
011-771-1501
info@yurinokai.jp
NO
2019 | Year | 03 | Month | 05 | Day |
Unpublished
69
Completed
2019 | Year | 02 | Month | 20 | Day |
2019 | Year | 02 | Month | 20 | Day |
2019 | Year | 03 | Month | 12 | Day |
2019 | Year | 07 | Month | 17 | Day |
2019 | Year | 02 | Month | 22 | Day |
2020 | Year | 02 | Month | 23 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040982